Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

In-Patient Treatment of Fibromyalgia: A Controlled Nonrandomized Comparison of Conventional Medicine versus Integrative Medicine including Fasting Therapy.

Michalsen A, Li C, Kaiser K, Lüdtke R, Meier L, Stange R, Kessler C.

Evid Based Complement Alternat Med. 2013;2013:908610. doi: 10.1155/2013/908610. Epub 2013 Jan 23.

2.

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.

Arthritis Rheum. 2004 Sep;50(9):2974-84.

4.

Additive Complex Ayurvedic Treatment in Patients with Fibromyalgia Syndrome Compared to Conventional Standard Care Alone: A Nonrandomized Controlled Clinical Pilot Study (KAFA Trial).

Kessler CS, Ostermann T, Meier L, Stapelfeldt E, Schütte S, Duda J, Michalsen A.

Evid Based Complement Alternat Med. 2013;2013:751403. doi: 10.1155/2013/751403. Epub 2013 Sep 1.

5.

Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.

Gür A, Karakoc M, Nas K, Cevik R, Sarac J, Ataoglu S.

Rheumatol Int. 2002 Sep;22(5):188-93. Epub 2002 Jul 6.

PMID:
12215864
6.

Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.

Arnold LM, Hirsch I, Sanders P, Ellis A, Hughes B.

Arthritis Rheum. 2012 Jul;64(7):2387-97. doi: 10.1002/art.34390.

7.

Effect of pilates training on people with fibromyalgia syndrome: a pilot study.

Altan L, Korkmaz N, Bingol U, Gunay B.

Arch Phys Med Rehabil. 2009 Dec;90(12):1983-8. doi: 10.1016/j.apmr.2009.06.021.

PMID:
19969158
8.

A randomized placebo-controlled study of noninvasive cortical electrostimulation in the treatment of fibromyalgia patients.

Hargrove JB, Bennett RM, Simons DG, Smith SJ, Nagpal S, Deering DE.

Pain Med. 2012 Jan;13(1):115-24. doi: 10.1111/j.1526-4637.2011.01292.x.

PMID:
22233397
9.

Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.

Arnold LM, Zhang S, Pangallo BA.

Clin J Pain. 2012 Nov-Dec;28(9):775-81. doi: 10.1097/AJP.0b013e3182510295.

PMID:
22971669
10.

Comparison of manual lymph drainage therapy and connective tissue massage in women with fibromyalgia: a randomized controlled trial.

Ekici G, Bakar Y, Akbayrak T, Yuksel I.

J Manipulative Physiol Ther. 2009 Feb;32(2):127-33. doi: 10.1016/j.jmpt.2008.12.001.

PMID:
19243724
11.

Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.

Bennett R, Russell IJ, Choy E, Spaeth M, Mease P, Kajdasz D, Walker D, Wang F, Chappell A.

Clin Ther. 2012 Apr;34(4):824-37. doi: 10.1016/j.clinthera.2012.02.013. Epub 2012 Mar 14.

PMID:
22421576
12.

A randomized, controlled, trial of controlled release paroxetine in fibromyalgia.

Patkar AA, Masand PS, Krulewicz S, Mannelli P, Peindl K, Beebe KL, Jiang W.

Am J Med. 2007 May;120(5):448-54.

PMID:
17466657
13.

An open-label study of quetiapine in the treatment of fibromyalgia.

Hidalgo J, Rico-Villademoros F, Calandre EP.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):71-7. Epub 2006 Aug 4.

PMID:
16889882
14.

Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.

Russell IJ, Perkins AT, Michalek JE; Oxybate SXB-26 Fibromyalgia Syndrome Study Group.

Arthritis Rheum. 2009 Jan;60(1):299-309. doi: 10.1002/art.24142.

15.

Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management.

Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A, Allaz AF, Vischer TL.

Ann Rheum Dis. 2004 Mar;63(3):290-6.

16.

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Distler O, Eich W, Dokoupilova E, Dvorak Z, Fleck M, Gaubitz M, Hechler M, Jansen JP, Krause A, Bendszus M, Pache L, Reiter R, Müller-Ladner U.

Arthritis Rheum. 2010 Jan;62(1):291-300. doi: 10.1002/art.25062.

17.

History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.

Pae CU, Masand PS, Marks DM, Krulewicz S, Han C, Peindl K, Mannelli P, Patkar AA.

World J Biol Psychiatry. 2009;10(4 Pt 2):435-41. doi: 10.1080/15622970902789155.

PMID:
19382010
18.

Venlafaxine treatment of fibromyalgia.

Sayar K, Aksu G, Ak I, Tosun M.

Ann Pharmacother. 2003 Nov;37(11):1561-5.

PMID:
14565792
19.

Low-frequency pulsed electromagnetic field therapy in fibromyalgia: a randomized, double-blind, sham-controlled clinical study.

Sutbeyaz ST, Sezer N, Koseoglu F, Kibar S.

Clin J Pain. 2009 Oct;25(8):722-8. doi: 10.1097/AJP.0b013e3181a68a6c.

PMID:
19920724
20.

α1-Antitrypsin in fibromyalgia: results of a randomized, placebo-controlled, double-blind and crossover pilot trial.

Alegre C, Barceló M, Jardí R, Rodríguez-Frias F, Camprubí S.

Musculoskeletal Care. 2012 Sep;10(3):178-83. doi: 10.1002/msc.1000. Epub 2011 Dec 22.

PMID:
22190533

Supplemental Content

Support Center